156 related articles for article (PubMed ID: 12228198)
1. Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial.
Pentz RD; Flamm AL; Sugarman J; Cohen MZ; Daniel Ayers G; Herbst RS; Abbruzzese JL
J Clin Oncol; 2002 Sep; 20(18):3785-91. PubMed ID: 12228198
[TBL] [Abstract][Full Text] [Related]
2. Perceptions of cancer patients and their physicians involved in phase I trials.
Daugherty C; Ratain MJ; Grochowski E; Stocking C; Kodish E; Mick R; Siegler M
J Clin Oncol; 1995 May; 13(5):1062-72. PubMed ID: 7738612
[TBL] [Abstract][Full Text] [Related]
3. Altruism among participants in cancer clinical trials.
Truong TH; Weeks JC; Cook EF; Joffe S
Clin Trials; 2011 Oct; 8(5):616-23. PubMed ID: 21813584
[TBL] [Abstract][Full Text] [Related]
4. Reality testing in cancer treatment: the phase I trial of endostatin.
Ryan DP; Penson RT; Ahmed S; Chabner BA; Lynch TJ
Oncologist; 1999; 4(6):501-8. PubMed ID: 10631694
[TBL] [Abstract][Full Text] [Related]
5. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
[TBL] [Abstract][Full Text] [Related]
6. Endostatin: are the 2 years up yet?
Schellens JH; Ratain MJ
J Clin Oncol; 2002 Sep; 20(18):3758-60. PubMed ID: 12228194
[No Abstract] [Full Text] [Related]
7. Factors that influence a patient's decision to participate in a phase I cancer clinical trial.
Schutta KM; Burnett CB
Oncol Nurs Forum; 2000 Oct; 27(9):1435-8. PubMed ID: 11058975
[TBL] [Abstract][Full Text] [Related]
8. The "cure" for cancer: can the media report the hope without the hype?
Daugherty CK
J Clin Oncol; 2002 Sep; 20(18):3761-4. PubMed ID: 12228195
[No Abstract] [Full Text] [Related]
9. Motivations and Decision Making Processes of Men With X-linked Retinoschisis Considering Participation in an Ocular Gene Therapy Trial.
Turriff A; Blain D; Similuk M; Biesecker B; Wiley H; Cukras C; Sieving PA
Am J Ophthalmol; 2019 Aug; 204():90-96. PubMed ID: 30885710
[TBL] [Abstract][Full Text] [Related]
10. Phase I participants' views of quality of life and trial participation burdens.
Cohen MZ; Slomka J; Pentz RD; Flamm AL; Gold D; Herbst RS; Abbruzzese JL
Support Care Cancer; 2007 Jul; 15(7):885-90. PubMed ID: 17252219
[TBL] [Abstract][Full Text] [Related]
11. Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey.
Moorcraft SY; Marriott C; Peckitt C; Cunningham D; Chau I; Starling N; Watkins D; Rao S
Trials; 2016 Jan; 17():17. PubMed ID: 26745891
[TBL] [Abstract][Full Text] [Related]
12. Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations.
Itoh K; Sasaki Y; Fujii H; Ohtsu T; Wakita H; Igarashi T; Abe K
Br J Cancer; 1997; 76(1):107-13. PubMed ID: 9218741
[TBL] [Abstract][Full Text] [Related]
13. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
[TBL] [Abstract][Full Text] [Related]
14. Shouting 'cure!'--or whispering 'hope'--in a crowded cancer ward.
Healy BP
J Womens Health; 1998 Jun; 7(5):489-90. PubMed ID: 9650147
[No Abstract] [Full Text] [Related]
15. Understanding how coping strategies and quality of life maintain hope in patients deliberating phase I trial participation.
van der Biessen DA; van der Helm PG; Klein D; van der Burg S; Mathijssen RH; Lolkema MP; de Jonge MJ
Psychooncology; 2018 Jan; 27(1):163-170. PubMed ID: 28665008
[TBL] [Abstract][Full Text] [Related]
16. Parents' and children's comprehension and decision in a paediatric early phase oncology trial: a prospective study.
Béranger A; Bouazza N; de Haut de Sigy A; Foubert-Wenc AC; Davous D; Aerts I; Geoerger B; Auvrignon A; Brethon B; Leblond P; Corradini N; André N; Martinez H; Dupont JK; Doz F; Chappuy H
Arch Dis Child; 2019 Oct; 104(10):947-952. PubMed ID: 30472665
[TBL] [Abstract][Full Text] [Related]
17. Are angiostatin and endostatin cures for cancer?
Harris AL
Lancet; 1998 May; 351(9116):1598-9. PubMed ID: 9620709
[No Abstract] [Full Text] [Related]
18. Antitumor interaction of short-course endostatin and ionizing radiation.
Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
[TBL] [Abstract][Full Text] [Related]
19. Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group.
Estlin EJ; Cotterill S; Pratt CB; Pearson AD; Bernstein M
J Clin Oncol; 2000 May; 18(9):1900-5. PubMed ID: 10784630
[TBL] [Abstract][Full Text] [Related]
20. Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.
Meropol NJ; Weinfurt KP; Burnett CB; Balshem A; Benson AB; Castel L; Corbett S; Diefenbach M; Gaskin D; Li Y; Manne S; Marshall J; Rowland JH; Slater E; Sulmasy DP; Van Echo D; Washington S; Schulman KA
J Clin Oncol; 2003 Jul; 21(13):2589-96. PubMed ID: 12829680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
